Albany, NY, March 30, 2016 -- Driven by the rising incidence of conditions such as anaphylaxis in developed countries and the creation of a favorable reimbursement scenario by governments across the world, the global auto injectors market is poised to log a CAGR of 18.6% from 2014 to 2020. These findings are published in Transparency Market Research’s study, titled ‘Auto-Injectors Market - Global Industry Analysis, Size, Share, Growth, Trends and Forecast, 2014 - 2020’.
Get Sample Report Copy ofAuto Injectors Market: http://www.transparencymarketresearch.com/sample/sample.php?flag=S&rep_id=4199
The study states that the global auto-injectors market will rise from its 2013 valuation of US$665.0 mn to rise to US$2.5 bn by 2020, with enormous opportunities existing in RoW markets and emerging economies. An alarming increase in the prevalence of rheumatoid arthritis and various food allergies will further create opportunities for the growth of the auto injectors market globally. TMR analysts identify a major roadblock standing in the way of companies trying to occupy a larger revenue share in the auto-injectors market: The high prices of auto-injectors. The price factor assumes greater importance when it comes to patients in emerging economies, where, incidentally, the most lucrative growth opportunities lie.
Even so, the demand for auto injectors will continue to rise consistently as patients opt to choose these products for their ease of use, even during self-administration. The report segments the global auto injectors market on the basis of product type, manufacturing design, therapeutic application, and geography. On the basis of product type, the market is segmented into prefilled or disposable auto injectors and fillable or reusable auto injectors. Given their unmatched ease of use, pre-filled auto injectors made up the largest segment in the auto injectors market by product type.
Browse Market Research Report on Auto Injectors Market: http://www.transparencymarketresearch.com/global-auto-injectors-market.html
Likewise, using manufacturing design as a criterion, the global auto-injectors market has been segmented into customized and standardized auto injectors. Although the standardized injectors segment was the larger one in 2013, the growth of the customized auto-injectors segment will be the fastest through the report’s forecast period.Moving further, the report segments the auto-injectors market by therapeutic application into anaphylaxis, rheumatoid arthritis, multiple sclerosis, and others. The high prevalence of anaphylaxis has created a massive demand for auto injectors for administrating drugs to people suffering from this condition. This factor has made the anaphylaxis the largest application segment in the auto injectors market.
Browse Research Blog at http://www.tmrblog.com/2015/08/auto-injectors-market.html
From the geographical standpoint, the market for auto injectors is segmented into North America, Asia Pacific, Europe, and Rest of the World (RoW). Claiming a 70% stake in the global auto-injectors market, North America was seen to be the largest regional market in 2013. While the dominant position of North America will not see a drastic change, the Asia Pacific market will report the fastest rate of growth. The key recommendations of TMR’s analysts, discussed in detail in the report, include: Channeling investments into China and India, spearheading innovation in auto injectors, and improving consumer awareness through marketing campaigns.
Companies profiled in detail in the auto-injectors market report include: Pfizer, Inc., Becton, Dickinson & Co., Mylan, Inc., Antares Pharma Inc., Novartis International AG, Unilife Corp., Ypsomed Holding AG, Biogen Idec, and Scandinavian Health Ltd.
Other Trending Reports by TMR:
- Teleradiology Market: http://www.transparencymarketresearch.com/teleradiology-technology-market.html
- Dental Consumables Market: http://www.transparencymarketresearch.com/dental-consumables-market.html
- Knee Cartilage Repair Market: http://www.transparencymarketresearch.com/knee-cartilage-repair-market.html
About Us:
Transparency Market Research (TMR) is a U.S. based provider of syndicated research, customized research, and consulting services. TMR’s global and regional market intelligence coverage includes industries such as pharmaceutical, chemicals and materials, technology and media, food and beverages, and consumer goods, among others. Each TMR research report provides clients with a 360-degree view of the market with statistical forecasts, competitive landscape, detailed segmentation, key trends, and strategic recommendations.
Mr.Sudip.S 90 State Street, Suite 700 Albany, NY 12207 United States. Tel: +1-518-618-1030 USA - Canada Toll Free: 866-552-3453 Email: [email protected] Website: http://www.transparencymarketresearch.com Blog: http://www.tmrblog.com/


Huawei Expands Vietnam Presence Through Strategic Partnership with SHB Bank
Tesla Q1 Earnings Preview: Robotaxi Delays and SpaceX Merger Speculation Grow
Eli Lilly in Talks to Acquire Kelonia Therapeutics for Over $2 Billion
Want to cut your energy bills? Here’s how five experts are doing it
J.P. Morgan Downgrades Essity AB on Rising Costs and Weak Earnings Outlook
China Food Delivery Stocks Dip as Regulators Crack Down on “Ghost Deliveries”
Chinese Robotics Stocks React as Humanoid Robot Marathon Sparks Competition Concerns
Indian Refiners Use Yuan via ICICI Bank to Pay for Iranian Oil Under U.S. Sanctions Waiver
Netflix Q2 Profit Warning Sends Shares Tumbling as Reed Hastings Exits
Apple Wins ITC Ruling, Keeping Blood-Oxygen Feature on Apple Watch
Polymarket Seeks $400M Funding Round, Targets $15B Valuation Amid Prediction Market Boom
CATL Stock Hits Record High After Q1 2025 Earnings Surge
Elon Musk's Terafab Foundry Courts Top Chipmaking Giants for AI Self-Sufficiency Push
NiSource Signs Long-Term Energy Deals with Alphabet and Amazon to Power Indiana Data Centers
Australia Extends Fuel Sulphur Relaxation Amid Iran War Supply Disruptions
Japan to Subsidize Sony's Image Sensor Plant in Kumamoto with $380 Million
AEVEX Raises $320 Million in IPO Amid Surging Defense Sector Demand 



